top of page
Lecture 22: Growth Factors in Cancer
Gerald A Soff MD
Hanny Al-Samkari M.D.
Presentation Date:
March 6, 2025
> Cytopenia resulting from chemotherapy and other cancer treatments, is associated with morbidity/ mortality, and may negatively impact cancer outcomes.
> The development of therapeutic Hematopoietic Growth Factors has been one of the most impactful contributions to cancer care.
> In this presentation we will discuss the approach to cytopenia and the current understanding of appropriate use of growth factors in cancer patients.
Gerald A. Soff MD
Chief, Classical Hematology Service
Sylvester Comprehensive Cancer Center,
University of Miami Health System
gas199@Miami.edu
Disclosures:
> Research Support (Past 2 years): Amgen, Sobi Pharmaceuticals, Anthos Therapeutics, Alpine Immune Sciences (Data Safety Monitoring Committee)
> Advisory Boards (Past 2 years): Sobi Pharmaceuticals, Sanofi, Agios Pharmaceuticals.
Hanny Al-Samkari, M.D.
Hematology Oncology Division
Massachusetts General Hospital
hal-samkari@mgh.Harvard.edu
Research Support: Agios, Sobi, Amgen, Alpine Immune Sciences (Data Safety Monitoring Committee), Novartis, Vaderis
Consultancy, Agios, Sobi, Argenx, Novartis, Alnylam, Sanofi, Amgen, Pharmacosmos
> If you feed them, they will grow!
Starting in 2025, lectures are eligible for Continuing Education Credit.
Link for CE:
bottom of page